IRIS
CIPRANDI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.251
AS - Asia 1.451
EU - Europa 989
SA - Sud America 246
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 4.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.197
CN - Cina 454
SG - Singapore 448
IE - Irlanda 318
HK - Hong Kong 205
BR - Brasile 195
RU - Federazione Russa 159
VN - Vietnam 157
DE - Germania 130
FI - Finlandia 96
FR - Francia 75
IN - India 61
IT - Italia 43
GB - Regno Unito 39
SE - Svezia 38
CA - Canada 28
ZA - Sudafrica 22
IQ - Iraq 17
JP - Giappone 17
MX - Messico 17
AR - Argentina 16
PL - Polonia 15
PK - Pakistan 14
BD - Bangladesh 13
ID - Indonesia 12
NL - Olanda 12
AT - Austria 9
CO - Colombia 9
EC - Ecuador 9
ES - Italia 9
UA - Ucraina 9
EG - Egitto 8
TR - Turchia 7
VE - Venezuela 7
KE - Kenya 6
SA - Arabia Saudita 6
BE - Belgio 5
CL - Cile 5
LT - Lituania 5
PH - Filippine 5
RS - Serbia 5
UZ - Uzbekistan 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
MA - Marocco 4
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KR - Corea 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.993
Salva come PNG Salva come JPEG
Città #
Dublin 318
Ashburn 279
Chandler 271
San Jose 249
Singapore 247
Dallas 245
Hong Kong 204
Beijing 122
Princeton 66
Boardman 64
Helsinki 62
Lauterbourg 60
Lawrence 60
Munich 54
Los Angeles 53
Medford 53
Nanjing 42
Wilmington 40
Ho Chi Minh City 38
Shanghai 34
Redondo Beach 32
New York 31
Turku 30
Dong Ket 28
Hanoi 28
Ann Arbor 24
Nanchang 22
São Paulo 22
Dearborn 21
Buffalo 20
Changsha 20
Johannesburg 20
Santa Clara 19
Washington 19
Moscow 18
The Dalles 17
Tokyo 17
Hebei 16
Seattle 16
Council Bluffs 15
Da Nang 14
Hangzhou 14
Jacksonville 14
Frankfurt am Main 12
Redwood City 12
Tianjin 12
Warsaw 12
London 11
Orem 11
Shenyang 11
San Francisco 10
Boston 9
Brooklyn 9
Nuremberg 9
Toronto 9
Atlanta 8
Brasília 8
Pune 8
Chennai 7
Montreal 7
Phoenix 7
Stockholm 7
Amsterdam 6
Baghdad 6
Chicago 6
Fairfield 6
Lyon 6
Rio de Janeiro 6
Brussels 5
Cambridge 5
Columbus 5
Delhi 5
Denver 5
Hefei 5
Mexico City 5
Milan 5
Norwalk 5
Poplar 5
Porto Alegre 5
Thái Nguyên 5
Berlin 4
Bắc Ninh 4
Cairo 4
Charlotte 4
Falkenstein 4
Haiphong 4
Houston 4
Jakarta 4
Kunming 4
Lahore 4
Manchester 4
Woodbridge 4
Belgrade 3
Campinas 3
Chandigarh 3
City of London 3
Faisalabad 3
Genoa 3
Gunzenhausen 3
Jiaxing 3
Totale 3.385
Salva come PNG Salva come JPEG
Nome #
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment 147
Allergen-specific immunoglobulin E and allergic rhinitis severity 136
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 134
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 133
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 128
Asthma endotyping and biomarkers in childhood asthma 127
Phleum pratense molecular pattern across Italy 115
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 113
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 113
Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery 109
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 104
Allergen-specific immunoglobulin E and allergic rhinitis severity 103
Allergen immunotherapy in children and adolescents with respiratory diseases 103
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment 97
Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View 97
Antihistamines in children and adolescents: A practical update 97
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 93
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 92
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management 92
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 92
Biomarkers of immunotherapy response in patients with allergic rhinitis 89
Severe asthma in children: Current goals and unmet needs 89
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 88
Asthma control in children and adolescents: a study in clinical practice 85
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 84
Cough Remedies for Children and Adolescents: Current and Future Perspectives 83
Allergy and Otitis Media in Clinical Practice 80
Pentraxin 3 and D-dimer in children with asthma: A real-world study 77
Allergen immunotherapy and asthma 76
Immunotherapy and asthma in children 74
Asthma in children and adolescents: The control’asma project 73
Anxiety and depression in adolescents with asthma and in their parents: A study in clinical practice 72
Personalized therapies for the treatment of allergic rhinitis 72
Special Issues for Coronavirus Disease 2019 in Children and Adolescents 70
Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children 66
Attitude to food supplement use: a survey promoted by the Italian Society of Pediatric Allergy and Immunology 65
Allergic rhinoconjunctivitis: Pathophysiological mechanism and new therapeutic approach 64
The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors 64
Profiles of birch sensitization (Bet v 1, Bet v 2, and Bet v 4) and oral allergy syndrome across Italy 63
Complementary treatment of allergic rhinoconjunctivitis: The role of the nutraceutical lertal® 63
Foreword 63
The relevance of symptom perception in the management of severe asthma in adolescents 61
Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach 60
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 59
What are the effects of rhinitis on patients with asthma? 59
New approaches for identifying and testing potential new anti-asthma agents 58
Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice 58
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis 57
Focus on the cetirizine use in clinical practice: a reappraisal 30  years later 56
Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children? 55
The practical clinical relevance of rhinitis classification in children with asthma: outcomes of the “ControL'Asma” study 54
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy 54
The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world "ControL'Asma" study 54
Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough 52
The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents 52
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 51
Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis 48
Vitamin D3 in children with allergic asthma in clinical practice 47
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 46
COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission 46
The relevance of symptom perception in the management of severe asthma in adolescents 45
Cetirizine use in childhood: An update of a friendly 30-year drug 43
To prevent the allergic disease: The dream of the allergist 41
Letters to the Editor 40
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 38
Respiratory infections in allergic children: The preventive role of a multicomponent nutraceutical 33
Thermal water inhalation for allergic rhinitis and recurrent respiratory infections: a narrative review of the evidence 19
Totale 5.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.743
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 8 6 33
2021/2022282 1 2 12 6 10 18 5 17 11 11 41 148
2022/2023819 97 49 6 73 52 85 0 39 376 8 27 7
2023/2024410 44 58 38 38 35 105 20 30 2 25 5 10
2024/20251.017 18 74 30 52 22 52 67 43 242 29 143 245
2025/20262.121 189 158 293 194 288 119 492 90 193 105 0 0
Totale 5.071